BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37021767)

  • 41. Nitric oxide modulates recombinant human bone morphogenetic protein-2-induced corticocancellous autograft incorporation: a study in rat intertransverse fusion.
    Diwan AD; Khan SN; Cammisa FP; Sandhu HS; Lane JM
    Eur Spine J; 2010 Jun; 19(6):931-9. PubMed ID: 20063019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the osteogenesis and fusion rates between activin A/BMP-2 chimera (AB204) and rhBMP-2 in a beagle's posterolateral lumbar spine model.
    Zheng GB; Yoon BH; Lee JH
    Spine J; 2017 Oct; 17(10):1529-1536. PubMed ID: 28522401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
    Stambough JL; Clouse EK; Stambough JB
    Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years.
    Singh K; Smucker JD; Gill S; Boden SD
    J Spinal Disord Tech; 2006 Aug; 19(6):416-23. PubMed ID: 16891977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
    Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
    J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
    J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models.
    Boden SD; Moskovitz PA; Morone MA; Toribitake Y
    Spine (Phila Pa 1976); 1996 Nov; 21(22):2689-97. PubMed ID: 8961457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2.
    Burkus JK; Transfeldt EE; Kitchel SH; Watkins RG; Balderston RA
    Spine (Phila Pa 1976); 2002 Nov; 27(21):2396-408. PubMed ID: 12438990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of effects of rhBMP-2 on interbody fusion with a novel rat model.
    Okada R; Kaito T; Ishiguro H; Kushioka J; Otsuru S; Kanayama S; Bal Z; Kitaguchi K; Hashimoto K; Makino T; Takenaka S; Sakai Y; Yoshikawa H
    Spine J; 2020 May; 20(5):821-829. PubMed ID: 31901554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterotopic ossification following single-level anterior cervical discectomy and fusion: results from the prospective, multicenter, historically controlled trial comparing allograft to an optimized dose of rhBMP-2.
    Arnold PM; Anderson KK; Selim A; Dryer RF; Kenneth Burkus J
    J Neurosurg Spine; 2016 Sep; 25(3):292-302. PubMed ID: 27129045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of BMP-7 in a rat posterolateral intertransverse process fusion model.
    Salamon ML; Althausen PL; Gupta MC; Laubach J
    J Spinal Disord Tech; 2003 Feb; 16(1):90-5. PubMed ID: 12571490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion.
    Majid K; Tseng MD; Baker KC; Reyes-Trocchia A; Herkowitz HN
    Spine J; 2011 Jun; 11(6):560-7. PubMed ID: 20097616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
    Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
    Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
    Singh K; Dumonski M; Stanley T; Ponnappan R; Phillips FM
    Spine (Phila Pa 1976); 2011 Feb; 36(3):192-6. PubMed ID: 20634780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion.
    Abbah SA; Lam CX; Ramruttun AK; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2011 Oct; 36(21):1752-9. PubMed ID: 21673630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates.
    Wang M; Abbah SA; Hu T; Toh SY; Lam RW; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2013 Aug; 38(17):1452-8. PubMed ID: 23380826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.